دورية أكاديمية
Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study.
| العنوان: | Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study. |
|---|---|
| المؤلفون: | Calleja-Escudero, Jesús, Barrondo, Víctor, Rodriguez-Alonso, Andrés, Gómez-Veiga, Francisco, Bestard, Joan, Gómez-Caamaño, Antonio, Grandoulier, Anne-Sophie, Pérez-Sampietro, Maria, Chantada-Abal, Venancio, Poza de Celis, Raúl |
| المصدر: | Drugs Context ; ISSN:1745-1981 ; Volume:13 |
| بيانات النشر: | PubMed Central |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | androgen deprivation, concomitant, hormone therapy, quality of life, radiotherapy |
| الوصف: | Injectable extended-release formulations of luteinizing hormone-releasing hormone agonists (LHRHa) have simplified the treatment of prostate cancer with a satisfactory level of androgen castration. This study aims to determine the percentage of patients whose initial LHRHa prescription was renewed during follow-up, how many changed formulation and how their quality of life evolved. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.7573/dic.2024-2-2Test; https://pubmed.ncbi.nlm.nih.gov/38915919Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11195525Test/ |
| DOI: | 10.7573/dic.2024-2-2 |
| الإتاحة: | https://doi.org/10.7573/dic.2024-2-2Test https://pubmed.ncbi.nlm.nih.gov/38915919Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11195525Test/ |
| حقوق: | Copyright © 2024 Calleja-Escudero J, Barrondo V, Rodriguez-Alonso A, Gómez-Veiga F, Bestard J, Gómez-Caamaño A, Grandoulier AS, Pérez-Sampietro M, Chantada-Abal V, Poza de Celis R, on behalf of ANAREN Study Group. |
| رقم الانضمام: | edsbas.BED61EA0 |
| قاعدة البيانات: | BASE |
| DOI: | 10.7573/dic.2024-2-2 |
|---|